Agenus
AGEN
#9022
Rank
A$0.19 B
Marketcap
A$5.70
Share price
-7.11%
Change (1 day)
18.89%
Change (1 year)

P/E ratio for Agenus (AGEN)

P/E ratio as of December 2025 (TTM): -1.27

According to Agenus 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.26527. At the end of 2017 the company had a P/E ratio of -2.62.

P/E ratio history for Agenus from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2017-2.62-4.66%
2016-2.75-29.01%
2015-3.87-33.37%
2014-5.81158.11%
2013-2.25-72.56%
2012-8.21

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Merck
MRK
13.1-1,137.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
13.6-1,172.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
20.2-1,694.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-8.17 545.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
17.7-1,496.14%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.